Tuesday, 02 January 2024 12:17 GMT
عربي


               US          Europe          Arab          Asia          Africa    
|      Politics          Economy     Oil&Energy         
                 Entertainment          Sport

NOTICE TO DISREGARD -- Bright Meds


2026-02-04 01:02:14
(MENAFN- GlobeNewsWire - Nasdaq) NEW YORK, January, Feb. 04, 2026 (GLOBE NEWSWIRE) -- We are advised by Bright Meds that journalists and other readers should disregard the news release, "Brightmeds Tirzepatide Investigated: Is It Safe and Legit for Weight Loss? Exploring Safety, Side Effects, and Results (2026 Analysis)" issued January 21, 2026, 10:06 ET, over GlobeNewswire.


MENAFN04022026004107003653ID1110692746



GlobeNewsWire - Nasdaq

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Tags

Label

Comments

No comment

Category

Date
Search